chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pins and needles in "my" hands and feet.; Numbness in "my" hands, feet, arms, legs, and occasionally neck and face.; Sharp prickling sensation; Extremely uncomfortable. It is most prominent in the arm in which "I" received the vaccine.; "I" am experiencing nausea; Vertigo; A mid-grade fever; A sore throat; Fatigue; Body aches; Headaches; Swollen lymph nodes; Injection site soreness; This is a spontaneous report from a non-contactable consumer, the patient. An 18-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO165) via an unspecified route of administration in the left arm on 22Apr2021 at 09:30 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history included iron deficiency anaemia, severe concussion in July 2022, COVID-19 and penicillin allergy. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included ascorbic acid/ ferrous fumarate (Vitamin C) as iron supplements from an unknown date and unknown if ongoing. On 22Apr2021 at 09:30, immediately after the vaccination, the patient began experiencing pins and needles in her hands and feet. It was reported that the patient was kept in the clinic for 30 minutes in case of an allergic reaction. Since then, the patient had been experiencing this sensation as well as numbness in her hands, feet, arms, legs, and occasionally neck and face and sometimes it was escalated to a sharp prickling sensation and became extremely uncomfortable for the patient which was most prominent in the arm in which patient received the vaccine. Aside from this the patient also experienced nausea, vertigo, a mid-grade fever, a sore throat, fatigue, body aches, headaches, swollen lymph nodes, and injection site soreness. It was reported that the patient had COVID-19 before and experienced similar pins and needles but was less extreme and was only in her hands and feet. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pins and needles in her hands and feet, numbness in her hands, feet, arms, legs/ occasionally neck and face, sharp prickling sensation and extremely uncomfortable in the arm in which received the vaccine, nausea, vertigo, a mid-grade fever, a sore throat, fatigue, body aches, headaches, swollen lymph nodes and injection-site soreness was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
woke up feeling bad again; woke up so dizzy/the dizziness "wasn't that bad." Caller stated that this feeling of dizziness did not go away; couldn't stand up; This is a spontaneous report from a contactable consumer. This 74-year-old female consumer reported for herself. A 74-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE Solution for injection Lot number was not reported) via an unspecified route of administration in arm right on 26Jan2021 08:00 as dose 1, single (age at vaccination: 74 years) for COVID-19 immunisation. Medical history included ongoing allergy to mountain cedar on an unknown date diagnosed at the age of 30. Concomitant medications were not reported. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was none. Additional vaccines administered on same date of the Pfizer suspect was none. Prior Vaccinations (within 4 weeks), any other vaccinations within four weeks prior to the first administration date of the suspect vaccines was none. The adverse events following prior vaccinations was none. Patient received the first dose of the Covid vaccine on 26Jan2021 and was scheduled to receive the second dose on 16Feb2021. On 28Jan2021 at 08:00, patient experienced that she woke up so dizzy and couldn't stand up, and her husband had to hold her, this feeling lasted for two hours and then eased off. On 29Jan2021, she woke up feeling bad again and on the morning of 30Jan2021, the dizziness was not that bad and stated that this feeling of dizziness did not go away until that next Tuesday in February. She called her doctor in which they believe she may be experiencing this because of cedar allergies. Patient wants to know if she should receive her second dose of the vaccine. She does not felt dizzy anymore. Stated that she had allergies to cedar and had never got that dizzy. The clinical outcome of the event woke up feeling bad again was unknown and rest of the events on 02Feb2021 was resolved.  Follow-up attempts completed. No further information expected.
Tingly in the arm; Warmness in the arm; Itching; Rash on the arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingly in the arm), FEELING HOT (Warmness in the arm), PRURITUS (Itching) and RASH (Rash on the arm) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced PARAESTHESIA (Tingly in the arm), FEELING HOT (Warmness in the arm), PRURITUS (Itching) and RASH (Rash on the arm). At the time of the report, PARAESTHESIA (Tingly in the arm), FEELING HOT (Warmness in the arm), PRURITUS (Itching) and RASH (Rash on the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
patient reported have hives on the injection site after 2 days of obtaining  2nd dose of Shingrix
chills; low grade fever; nausea; extreme joint pain; muscle pain,; extreme headache; Had to leave work, used a sick day; This case was reported by a consumer via other manufacturer and described the occurrence of chills in a 53-year-old female patient who received Herpes zoster (Shingrix) (batch number 333TE, expiry date unknown) for prophylaxis.   Co-suspect products included COVID-19 VACCINE for prophylaxis.   Concurrent medical conditions included allergy (Unknown Allergy).   On 10th November 2022, the patient received Shingrix and COVID-19 VACCINE. On 11th November 2022 08:00, 1 days after receiving Shingrix, the patient experienced chills, fever, nausea, joint pain, muscle pain, headache and sickness. On an unknown date, the outcome of the chills, fever, nausea, joint pain, muscle pain, headache and sickness were recovering/resolving.   It was unknown if the reporter considered the chills, fever, nausea, joint pain, muscle pain, headache and sickness to be related to Shingrix.     Additional Information: GSK Receipt Date: 14-NOV-2022 Reporter's comments: The reporter had reported that after taking the Shingrix and COVID-19 vaccine, the patient had experienced chills, low-grade fever, nausea, extreme joint pain and muscle pain, extreme headache.  She had to leave work and she have not used a sick day in over 2 years. The patient was tested positive for COVID-19 before and after the Shingrix vaccination. The reporter had consented to follow-up. Additional supportive information: It was unknown if the reporter considered the chills, fever, nausea, joint pain, muscle pain, headache and sickness to be related to COVID-19 vaccine and  days after receiving COVID-19 vaccine the patient experienced chills, fever, nausea, joint pain, muscle pain, headache and sickness.
I received the vaccination at 11:00 am and felt absolutely nothing at the time of the shot.  I was 100% fine until around 3:00 pm when I felt very light headed while sitting on the couch. I am a fainter and felt like i was going to faint.  I called my husband and with that I broke out in a very cold sweat and then fell asleep for 2 hours.  I was cold from sleeping in the cold sweat I believe but nothing after.
Patient reported feeling dizzy and unwell shortly after receiving vaccine. Patient went to the ER where here blood pressure was under control. She received steroids from the ER and was told to take Benadryl when she returned home.
School nurse called office to report pt. was to her office today "fever,vesicles on face including eye area, vesicles also on head, neck & ankles. No vesicles on any other parts of her body. Some vesicles were scabbed over.Some vesicles were popping" RN instructed her to have child dismissed from school immediately, for the child to be seen by Pediatrician asap today.RN instructed her on "adverse reactions following vaccinations-MMR & Varicella & MMRV" per The Pink Book. RN also instructed her on "what are the risks from MMR & Varicella vaccine" per the VIS. Hard copies also faxed to her. RN also reported the VAERS to the Epidemiology nurse at office.
Ringing in ear/ Fuzzy sound; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in ear/ Fuzzy sound) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TINNITUS (Ringing in ear/ Fuzzy sound). At the time of the report, TINNITUS (Ringing in ear/ Fuzzy sound) had not resolved. Not Provided          No concomitant medications were reported.  No treatment information was provided.
Engerix-b was administered, Expiration 11/12/2021; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received HBV (Engerix B adult) (batch number 54A32, expiry date 12th November 2021) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 15th November 2021, the patient received Engerix B adult and Engerix B Pre-Filled Syringe Device. On 15th November 2021, unknown after receiving Engerix B adult and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The health care professional reported that an expired adult Engerix-B was administered to the patient.  The reporter had not provided identifiable information. The reporter had not reported any reactions. The consent to follow up granted by email.
Illness; Insomnia; Diarrhoea; Chills; Nausea; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Illness), INSOMNIA (Insomnia), DIARRHOEA (Diarrhoea), CHILLS (Chills) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Illness), INSOMNIA (Insomnia), DIARRHOEA (Diarrhoea), CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, ILLNESS (Illness), INSOMNIA (Insomnia), DIARRHOEA (Diarrhoea), CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.            Concomitant product use was not provided by the reporter.  No treatment information was provided.  Reporter's sister in law experienced similar events after the second dose .   This case was linked to MOD-2021-370198 (Patient Link).
On 9/22/99, the pt went to her pediatrician with complaints of fevers, aches, and decreased energy. She had joint pain. She had reportedly pain in her knee, foot, and wrist. She was seen by an orthopedist and during this examination it was thought that the pt's complaints were not from an orthopedic injury. The reporter indicated that it was the impression of the pt's physician that the adverse events were a rheumatic illness with a lupus-like presentation. Autoimmune hepatitis is also currently being ruled out. Treatment of the adverse events was not specified. No other details were provided.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapy was not reported. On 04-AUG-2016, the patient was vaccinated with an improperly stored dose of PROQUAD (lot # M010478 with expiry date on 01-SEP-2017, therapy type, dose and route of administration were not reported). No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Booster dose of the Pfizer Covid vaccine; that night I felt congestion; little dizzy that evening; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (COMIRNATY), administration date 09Nov2021 (Lot number: FH8030, Expiration Date: 31May2022) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunization; Bnt162b2 (Dose 2), for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 09Nov2021, described as "Booster dose of the Pfizer Covid vaccine"; NASAL CONGESTION (non-serious) with onset 09Nov2021, described as "that night I felt congestion"; DIZZINESS (non-serious) with onset Nov2021, described as "little dizzy that evening".  Clinical course: She received the booster dose of the Pfizer Covid vaccine on 09Nov2021, and that night she felt congestion and a little dizzy that evening, but she was fine then.  Additional information: She thought was it unusual to get congestion a side effects of the vaccine?, because the way she felt, was more after she received the flu shot, and she did not go there to get the flu shot, but she felt like her side effects felt like the flu vaccine, she went back to them, and they did not have an answer. She was fine then. She just wondering if they gave her the flu vaccine instead. It has been in the news a lot lately, where the pharmacist over diluted the vile, or they gave the wrong thing.  No follow-up attempts are possible. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: deleted event I pulled back a little do you think I received the whole dose of the vaccine coded to LLT underdose and LLT vaccination error.
#1-Local injection area burned for 5 minutes, post vax, had a lump for 2 weeks, felt listliss. #2-Immediately, post vax, my right arm had sharp pains in all joints and muscles for 5 minutes. Deltoid muscle hurt for 4 days, still felt listless. #3-Had no pain, just tired and listless all the time. Had chills and fever 3 days later, for 1 night only. Still feel listless and have no energy.  Follow up 06/05/2000: "Patient partially recovered from adverse event.  Fatigue, occasional night sweats."
"Hard lump" at injection site and into "armpit" area. Feels this is some sort of "reaction". This was reported via telephone and area has not been visually assessed by us.
he was diagnosed with diabetes. It was pretty severe at the beginning.; This spontaneous case was reported by a physician and describes the occurrence of DIABETES MELLITUS (he was diagnosed with diabetes. It was pretty severe at the beginning.) in a 72-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 041H22A) for COVID-19 prophylaxis.     The patient's past medical history included Pancreatitis, Glucose urine present and Coronary artery bypass (Quadruple coronary artery bypasses). Concurrent medical conditions included Hypertension, Hypocholesteremia and Diabetes (He was a high risk patient).    On 16-Dec-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In February 2023, the patient experienced DIABETES MELLITUS (he was diagnosed with diabetes. It was pretty severe at the beginning.) (seriousness criterion medically significant). In 2023, DIABETES MELLITUS (he was diagnosed with diabetes. It was pretty severe at the beginning.) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Glycosylated haemoglobin: His hemoglobin A1C was back to normal and he was on a minimal dose of oral hypoglycemic agents.. On an unknown date, Weight decreased: Lost 30 pounds.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. He was able to be controlled with diet and oral hypoglycemic agents. Since he went on the oral agents back in February, his diabetes has markedly recovered. Apparently he needed a lot of treatment in the beginning and his pancreas had made a recovery. Company comment- This is a regulatory authority case concerning a 72-year-old male patient with medical history of coronary artery bypass, hypertension and COVID-19 (1 month before vaccination) who experienced the unexpected and serious (medically significant) event diabetes mellitus approximately 2 months after a fifth dose of mRNA-1273 vaccine was administered. It was reported patient´s diabetes was able to be controlled with diet and oral hypoglycemic agents. Since he went on the oral agents, his diabetes has markedly recovered. Apparently, he needed a lot of treatment in the beginning and his pancreas had made a recovery. Medical history of COVID-19 remains as a contributory risk factor. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2023-741615 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-741615:Same patient, Monovalent moderna vaccine
3 doses administered past the 30 use by date expiration; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (3 doses administered past the 30 use by date expiration) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (3 doses administered past the 30 use by date expiration). In November 2021, EXPIRED PRODUCT ADMINISTERED (3 doses administered past the 30 use by date expiration) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided.   This case was linked to MOD-2021-378185, MOD-2021-386455 (Patient Link).
Patient was given injection. Right after needle exited right arm deltoid muscle, she started bleeding, which was stopped with applied pressure for about 20-30 seconds. Patient's arm was visibly bruised and swelling of about a quarter size occurred at the site of injection.
Patient came in describing that she later that night experienced some swelling on inner left side of tongue and felt itching near ear, then fullness later near ear. Heart rate felt a little elevated but she did not check. She does not have a doctor so did not seek medical attention, just rested. Now on 11/11/19, still feels some fullness in ear and swelling on tongue. Will take Benadryl tonight once home and go to medical aid if it worsens or persists.
Pt returned next day, with swelling, extreme pain, he had chills, and flu-like symptoms night before -and chills down the spine. Feels better now.
On 3/21/21 his neck started bothering him and progressed into him not being able to use half of his face.  He was transported to Local Hospital. Where he was diagnosed with Bell's Palsy. He was given a treatment of Prednisone.  He was seen again by the Facility provider on 3/23/21 where the prednisone was continued on a tapered dose. Acyclovir was also added to the treatment.
We requested the vaccine for our daughter before she entered college. After the vaccine(on 8/23/07) she started to have leg tingling, which we thought was from a softball injury.She came home on spring break and was hospitalized from 3/02/08 to3/10/08 with leg paralysis that still cannot be explained. After massive doses of steroids and every test known to man (which came back normal) she regained the use of her legs 8 days later. We dont know if this will happen again or what caused it, but thought it should be reported due to others having the same thing happen. I have another daughter that is 10 that i was going to get the vaccine for, but want to make sure its safe before I do.if you have more questions, contact me because there was alot more than listed here that happened. 7/10/08-records received for DOS 3/2-3/10/08-DC DX: Chronic low back pain. Lower extremity weakness of unclear etiology.  Prior to admission developed worsening of lower back pain with weakness in lower extremities and numbness for 2 weeks. C/O pins and needles sensation. States no feeling in legs and unable to move them or walk.  PE: lower extremity strength 10/5 bilaterally.Chronic ingoing and outgoing problems for many years. C/O ecchymosis and easy bruising. All blood tests normal. Evaluated for possible adjustment disorder with anxiety over the conversion disorder.  8/28/08-office notes include neurology visit 12/17/07-impression:symptoms suggesting sacroiliac joint pain on right side, sensory changes and slight weakness and positive findings on straight leg raise suggest mild right L5 radiculopathy.
This spontaneous case reported by a consumer, describes the occurrence of tremor (shaking in hands) and dysstasia (difficulty standing-up) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included no adverse event. On Mar 4, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced tremor (shaking in hands) and dysstasia (difficulty standing-up). At the time of the report, tremor (shaking in hands) and dysstasia (difficulty standing-up) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information reported.